AirSculpt Technologies, Inc. (NASDAQ:AIRS – Get Free Report) was the target of unusually large options trading activity on Monday. Investors bought 3,985 call options on the stock. This is an increase of approximately 61% compared to the average daily volume of 2,477 call options.
Insider Activity at AirSculpt Technologies
In related news, major shareholder Jorey Chernett bought 40,000 shares of AirSculpt Technologies stock in a transaction that occurred on Friday, April 17th. The stock was acquired at an average price of $2.54 per share, with a total value of $101,600.00. Following the acquisition, the insider owned 7,053,761 shares of the company’s stock, valued at approximately $17,916,552.94. This represents a 0.57% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders have bought 810,150 shares of company stock worth $1,987,624. Insiders own 44.60% of the company’s stock.
Institutional Investors Weigh In On AirSculpt Technologies
A number of hedge funds and other institutional investors have recently made changes to their positions in AIRS. Balyasny Asset Management L.P. raised its position in shares of AirSculpt Technologies by 128.5% in the 2nd quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock valued at $5,380,000 after buying an additional 626,309 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of AirSculpt Technologies in the 4th quarter valued at approximately $1,991,000. Vanguard Group Inc. raised its position in shares of AirSculpt Technologies by 10.8% in the 3rd quarter. Vanguard Group Inc. now owns 782,543 shares of the company’s stock valued at $6,276,000 after buying an additional 76,291 shares in the last quarter. Geode Capital Management LLC raised its position in shares of AirSculpt Technologies by 4.6% in the 4th quarter. Geode Capital Management LLC now owns 403,163 shares of the company’s stock valued at $798,000 after buying an additional 17,889 shares in the last quarter. Finally, CenterBook Partners LP raised its position in shares of AirSculpt Technologies by 59.4% in the 3rd quarter. CenterBook Partners LP now owns 355,081 shares of the company’s stock valued at $2,848,000 after buying an additional 132,327 shares in the last quarter. 91.54% of the stock is currently owned by institutional investors and hedge funds.
AirSculpt Technologies Price Performance
AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) last released its quarterly earnings results on Tuesday, March 31st. The company reported ($0.02) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.02). AirSculpt Technologies had a negative net margin of 7.39% and a negative return on equity of 5.17%. The company had revenue of $33.44 million during the quarter. The company’s revenue for the quarter was down 14.8% compared to the same quarter last year. On average, analysts forecast that AirSculpt Technologies will post -0.06 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded shares of AirSculpt Technologies from a “sell” rating to a “hold” rating in a research note on Sunday, April 5th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, AirSculpt Technologies currently has an average rating of “Reduce” and a consensus target price of $6.00.
View Our Latest Research Report on AIRS
About AirSculpt Technologies
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
Featured Articles
- Five stocks we like better than AirSculpt Technologies
- Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand Now
- 3 Metals and Mining Stocks Riding the Commodity Supercycle
- Catching Falling Knives: Is Time to Buy These Beaten-Down Stocks?
- The Stars Are Aligning For Apple: Get Ready for $300
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
